The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.

In spite of nationwide vaccination of newborns against hepatitis B virus since 1992, hepatitis B virus infection remains a very common cause of chronic liver disease in Iran which should be dealt with for at least the next 30-50 years.